Dr. Kelly Mills

As the director of the Johns Hopkins Movement Disorders Division, Dr. Kelly Mills cares for patients who have movement disorders such as Parkinson’s disease, atypical parkinsonism, dystonia, ataxia, tremor and Huntington’s disease. He also evaluates and manages patients needing deep brain stimulation to manage their movement symptoms and provides botulinum toxin treatment for various disorders. In his research, Dr. Mills explores the cognitive dysfunction that can occur in movement disorders such as Parkinson’s disease. He is particularly interested in describing the role of the basal ganglia in cognition, especially in the context of various diseases that can affect this structure. His work focuses on clarifying how certain treatments might impact cognitive and psychiatric problems. For instance, Dr. Mills studies how deep brain stimulation, when used to treat movement symptoms, can impact cognitive function such as attention, memory or impulsivity. Dr. Mills is a Maryland native and a graduate of the University of Maryland School of Medicine, where he developed an interest in neurology and movement disorders. He trained at the University of California, San Francisco, where he completed his neurology residency as well as a clinical and research fellowship in movement disorders, with a particular emphasis on deep brain stimulation to treat Parkinson’s disease, tremor and dystonia.

Dr. Mills is rated as a Distinguished provider by MediFind in the treatment of Drug Induced Dyskinesia. His top areas of expertise are Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Deep Brain Stimulation, and Knee Replacement.

His clinical research consists of co-authoring 98 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of Drug Induced Dyskinesia.